Reference of 1317-39-1, In heterogeneous catalysis, catalysts provide a surface to which reactants bind in a process of adsorption. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.In an article, once mentioned the application of 1317-39-1, Name is Copper(I) oxide, is a conventional compound.
The present invention provides pharmaceutically active compounds of formula I STR1 wherein R1 is –H, –OH, –O(C1 -C4 alkyl), –OCOC6 H5, –OCO(C1 -C6 alkyl), or –OSO2 (C2 -C6 alkyl); R2 is –H, –OH, –O(C1 -C4 alkyl), –OCOC6 H5, –OCO(C1 -C6 alkyl), –OSO2 (C2 -C6 alkyl), or halo, providing when Z is –S–, R2 is not halo; R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; n is 2 or 3; and z is –O– or –S–; or a pharmaceutically acceptable salt thereof, for inhibiting restenosis.
Interested yet? Keep reading other articles of Reference of 106778-43-2!, Reference of 1317-39-1
Reference：
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”